Experiment: 2LEL

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
2	2D 1H-13C HSQC	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
3	2D 1H-13C HSQC	1.5 mM Cu(I)Cu(II)-CopK-1	95% H2O/5% D2O	100	6.7	ambient	298
4	3D HNCO	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
5	3D HNCA	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
6	3D HNCACB	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
7	3D HBHA(CO)NH	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
8	3D HCCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
9	3D 1H-13C NOESY	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
10	3D 1H-15N NOESY	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
11	2D 1H-13C HSQC	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298
12	2D 1H-13C HSQC	1.0 mM [U-100% 13C; U-100% 15N] Cu(I)Cu(II)-CopK-2	95% H2O/5% D2O	100	6.7	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	600
3	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	256
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	TopSpin		Bruker Biospin
3	data analysis	XEASY		Bartels et al.
4	processing	TALOS		Cornilescu, Delaglio and Bax
5	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
6	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.